Dec. 22, 2004 — The U.S. Food and Drug Administration (FDA) approved in October revisions to drug safety labeling to advise healthcare professionals of the following changes: use of the multidose ...
(Reuters) - The U.S. Food and Drug Administration issued a new warning on the use of the anticoagulant Lovenox in patients fitted with a spinal catheter because of the risk of spinal column bleeding ...
July 26, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ...
Emphasizing the tenet that antitrust laws are enacted to protect competition—and not competitors—the Third Circuit has rejected one competitor's claim that Sanofi-Aventis had an unfair advantage in ...
LONDON, Aug 26 (Reuters) - French drugmaker Sanofi-Aventis will continue a legal battle in the United States against a generic version of its blood clot preventer Lovenox, despite a court rebuff, it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback